Withdrawn: Treatment Failure and Empiric Antibiotic Choice for Hospitalized Patients With Community-Acquired Pneumonia: Β-Lactam/Β-Lactamase Inhibitor Combined With Macrolid or Fluoroquinolone Alone?
Abstract:Background
A considerable percentage of empirical antibiotic treatment fails in hospitalized patients with community-acquired pneumonia (CAP). β-lactams and macrolid (BLM) combination or respiratory fluoroquinolones (FQ) are the most frequently used in these patients. The aim of the present study is to compare the treatment failure (TF) rates in BLM and FQ treatment and to analyze the predictive factors of TF.
Method
Hospitalized patients who were initially treated with either BLM or FQ were … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.